Managing infections in patients with multiple myeloma

Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer

Neoadjuvant nivolumab for resectable lung cancer

Biomarkers of pembrolizumab response in head and neck cancer

Phase I taselisib results and a cell-free DNA assay

Front-line therapy of DIPG using IDO inhibitor with radiation and chemotherapy

AKT inhibitors in research and application

Effects of dasatinib on xenograft lung tumour models with YES1 overexpression

Reducing recurrence of advanced melanoma with pembrolizumab

Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.

Clinical development and economic prospects of CAR T cell immunotherapies

Response and safety profile of neoadjuvant nivolumab for resectable lung cancer